account_id none on file
legal_name InflaRx N.V.
ticker IFRX
cik 1708688
domain inflarx.de
linkedin_company_url none on file
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 13 executives 10 family 0
why_nownone on file
callsnone on file
filings
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our drugs.
filing / Mar 20, 2026 / receipt
we occupy approximately 4,900 square feet of office space in Planegg-Martinsried (near Munich), Germany under a lease that expires in
filing / Mar 20, 2026 / receipt
non-cancellable lease agreements mainly relating to the Company’s leases of office space. The lease terms of the Company’s
filing / Mar 20, 2026 / receipt
Niels Riedemann | Executive Director and Chief Executive Officer | 54 | 2007
filing / Mar 20, 2026 / receipt
Renfeng Guo | Executive Director and Chief Scientific Officer | 55 | 2007
filing / Mar 20, 2026 / receipt
Thomas Taapken | Chief Financial Officer | 60 | 2020
filing / Mar 20, 2026 / receipt
Camilla Chong | Chief Medical Officer | 60 | 2023
filing / Mar 20, 2026 / receipt
Derval O’Carroll | Senior Vice President, Global Head of Regulatory Affairs and Compliance | 60 | 2023
filing / Mar 20, 2026 / receipt
Nicolas Fulpius | Non-Executive Director and Chairman of the Board | 52 | 2007
filing / Mar 20, 2026 / receipt
Richard Brudnick | Non-Executive Director | 69 | 2019
filing / Mar 20, 2026 / receipt
Mark Kubler | Non-Executive Director | 51 | 2015
filing / Mar 20, 2026 / receipt
Anthony Gibney | Non-Executive Director | 55 | 2021
filing / Mar 20, 2026 / receipt
executives
| Anthony Gibney | Non-Executive Director | - | receipt |
| Camilla Chong | Chief Medical Officer | - | receipt |
| Derval O’Carroll | Senior Vice President, Global Head of Regulatory Affairs and Compliance | - | receipt |
| Hege Hellstrom | Non-Executive Director | - | receipt |
| Mark Kubler | Non-Executive Director | - | receipt |
| Nicolas Fulpius | Non-Executive Director and Chairman of the Board | - | receipt |
| Niels Riedemann | Executive Director and Chief Executive Officer | - | receipt |
| Renfeng Guo | Executive Director and Chief Scientific Officer | - | receipt |
| Richard Brudnick | Non-Executive Director | - | receipt |
| Thomas Taapken | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changesnone on file
mcp_package_hint
slug inflarx-n-v
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$